Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
plaque
Biotech
Takeda looks to 2026 FDA filing for Sotyktu rival zasocitinib
Takeda’s dermatology pill zasocitinib has won out in two key phase 3 trials as the Japanese pharma looks to file the drug in the U.S. next year.
Ben Adams
Dec 18, 2025 7:55am
Scientists pinpoint location of plaque ruptures
Jun 6, 2023 7:35am
Amyl raises $22M to target common element of protein aggregates
Jun 3, 2021 7:50am
No IPO? No problem: Alzheon bags $47M for Alzheimer's trial
Aug 20, 2020 12:01am
Clearing Alzheimer’s plaques by targeting a faulty APOE gene
Mar 29, 2018 10:31am
Newly discovered ‘molecular guardian’ keeps cholesterol in check
Nov 16, 2017 2:55pm
